Harrow
HROW
30.41
-1.72
-5.35%
Harrow
US · HROW
#3155 by market cap
30.41
-1.72
-5.35%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $91Market Newswire · 2026/3/18
-
H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/11/11
-
Rating change
Analysts' Top NA Picks: Harrow Health (HROW), Scribe Therapeutics Inc. (SCTX)TipRanks · 2026/8/20
-
Rating change
H.C. Wainwright Remains a Buy on Harrow Health (HROW)TipRanks · 2026/5/14
-
Rating change
B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/8/10
-
Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $88Market Newswire · 2026/11/11
-
Rating change
Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)TipRanks · 2026/8/20
-
Rating change
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Hims & Hers Health (HIMS) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 2026/5/12
-
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/10/5
-
Rating change
Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Caris Life Sciences, Inc. (CAI)TipRanks · 2026/8/7
-
Rating change
B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $60Market Newswire · 2026/5/14
-
Rating change
Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Amentum Holdings, Inc. (AMTM)TipRanks · 2026/8/11
-
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating, Announces Target Price $56Market Newswire · 2026/11/11
-
Rating change
B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $65Market Newswire · 2026/4/7
-
Rating change
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating, Announces Target Price $59Market Newswire · 2026/7/13
-
Rating change
Leerink Partners Initiates Harrow(HROW.US) With Buy Rating, Announces Target Price $45Market Newswire · 2026/9/9
-
Rating change
Craig-Hallum Maintains Harrow(HROW.US) With Buy RatingMarket Newswire · 2026/9/30
-
Rating change
William Blair Maintains Harrow(HROW.US) With Buy RatingMarket Newswire · 2026/10/5
-
Rating change
Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $88Market Newswire · 2026/5/13
-
BTIG Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $63Market Newswire · 2026/11/11
-
Rating change
Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $88Market Newswire · 2026/8/11
-
Rating change
A Quick Look at Today's Ratings for Harrow(HROW.US), With a Forecast Between $60 to $91Market Newswire · 2026/3/5
-
Rating change
BTIG Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $63Market Newswire · 2026/8/26
-
Rating change
H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/8/12
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Harrow discussion 0 comments